Updates are available Correction dated 2025-07-02
Click to view Correction: https://doi.org/10.1007/s00406-025-02058-0
-
Authors
Eder, Julia https://orcid.org/0000-0003-1330-804X
Dong, Mark Sen
Wöhler, Melanie
Simon, Maria S.
Glocker, Catherine
Pfeiffer, Lisa
Gaus, Richard
Wolf, Johannes
Mestan, Kadir
Krcmar, Helmut
Koutsouleris, Nikolaos
Schneider, Antonius
Gensichen, Jochen
Musil, Richard
Falkai, Peter
,
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG-GrK 2621)
Deutsche Forschungsgemeinschaft (DFG-GrK 2621)
Deutsche Forschungsgemeinschaft (DFG-GrK 2621)
Deutsche Forschungsgemeinschaft (DFG-GrK 2621)
Deutsche Forschungsgemeinschaft (DFG-GrK 2621)
Deutsche Forschungsgemeinschaft (DFG-GrK 2621)
Deutsche Forschungsgemeinschaft (DFG-GrK 2621)
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 24 January 2025
Accepted: 22 February 2025
First Online: 10 March 2025
Change Date: 2 July 2025
Change Type: Update
Change Details: The original online version of this article was revised due to incorrect Results, Description and Tables in the body text. Now, it has been Corrected.
Change Date: 2 July 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00406-025-02058-0
Declarations
:
: Richard Musil has received financial research support from the EU (H2020 No. 754740) and served as PI in clinical trials from Abide Therapeutics, Böhringer-Ingelheim, Emalex Biosciences, Lundbeck GmbH, Nuvelution TS Pharma Inc., Oryzon, Otsuka Pharmaceuticals, and Therapix Biosciences. Peter Falkai received research support/honoraria for lectures or advisory activities from Boehringer-Ingelheim, Janssen, Lundbeck, Otsuka, Recordati, and Richter. All other authors declare that they have no conflicts of interest.
